1Posgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de Mexico, Mexico City, Mexico
2Laboratorio de Medicina Translacional y Departamento de Tumores Gastro-Intestinales, Instituto Nacional de Cancerología, Mexico City, Mexico
3Programa en Biomedicina Molecular y Red de Biotecnología, Instituto Politécnico Nacional, Mexico City, Mexico
4Laboratorio de Medicina Genómica, Hospital Regional 1 de Octubre ISSSTE, Mexico City, Mexico
5Departamento de Infectómica y Patogénesis Molecular, CINVESTAV-IPN, Mexico City, Mexico
6Laboratorio de Investigación Translacional en Cáncer y Terapia Celular, Hospital de Oncología, Centro Médico Nacional Siglo XXI, Mexico City, Mexico
7Subdirección de Investigación Básica, Instituto Nacional de Medicina Genómica, Mexico City, Mexico
8Laboratorio de Genómica, Instituto Nacional de Cancerología, Mexico City, Mexico
Edited and reviewed by: Monica Venere, The Ohio State University, United States
✉*Correspondence: César López-Camarillo genomicas@yahoo.com.mx
This article was submitted to Cancer Molecular Targets and Therapeutics, a section of the journal Frontiers in Oncology
Copyright © 2020 Salinas-Vera, Gallardo-Rincón, García-Vázquez, Hernández-de la Cruz, Marchat, González-Barrios, Ruíz-García, Vázquez-Calzada, Contreras-Sanzón, Resendiz-Hernández, Astudillo-de la Vega, Cruz-Colin, Campos-Parra and López-Camarillo.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.